Exact Sciences (EXAS) Files Patent Infringement Lawsuit Against Geneoscopy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Exact Sciences Files Patent Infringement Lawsuit Against Geneoscopy
November 17, 2023 7:10 AM ESTCompany asserts that Geneoscopy infringed patented technology central to its Cologuard colorectal cancer screening test
MADISON, Wis., Nov. 17, 2023 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that it has filed a lawsuit against Geneoscopy, Inc. in the United States District... More



